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Abstract 
AIM: This study was aimed to compare the effects of ondansetron, haloperidol, and dexmedetomidine for 
reducing postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy.  
METHODS: This randomised clinical trial study was performed on p.patients who were candidates for abdominal 
hysterectomy referring to Taleghani hospital in Arak. In this study, 114 patients with abdominal hysterectomy were 
randomly assigned to three groups (ondansetron, haloperidol, and dexmedetomidine) using the cubull 
randomisation method.  
RESULTS: The results revealed a significant difference between the three groups of ondansetron, haloperidol 
and dexmedetomidine in terms of scorpion vomiting in recovery, 2 and 4 hours after surgery, and vomiting score 
was significantly lower in the ondansetron group compared with the other two groups (P = 0.04; P = 0.02; P = 
0.001). There was a significant difference between the three groups of e ondansetron, haloperidol and 
dexmedetomidine regarding the mean dose of metoclopramide in mg for 24 hours after surgery. Therefore, the 
dosage of dexmedetomidine in the ondansetron group was less than the other two groups (P = 0.001).  
CONCLUSION: these three drugs are effective in reducing PONV in patients undergoing a hysterectomy. 
However, the effect of ondansetron was found to be more than the other two drugs in reducing PONV. 
 
 
 
 
 
 
Introduction 
 
Despite the progression of the new and anti-
vomiting technique, Postoperative nausea and 
vomiting (PONV) is still one of the common 
complications after general anaesthesia and surgery 
in the immediate 24 postoperative hours, which 
causes increased unpleasant side effects, prolonged 
recovery and delayed discharge, as well as increased 
hospital costs. PONV also leads to loss of appetite, 
dehydration, and electrolyte imbalance [1] [2]. 
Vomiting may lead to wound dehiscence and 
oesophagal rupture, and pneumothorax, etc. The 
average incidence of PONV is reported to be 53-70% 
in high-risk patients. Therefore, the prevention of 
PONV increases patient satisfaction and reduces the 
cost of treatment. The prevalence of PONV should be 
monitored effectively, especially in high-risk patients, 
depending on the female gender, type of surgery, 
duration of surgery, duration of anaesthesia, and 
carbon dioxide content, as well as some visitors in 
Recovery. The chemo trigger zone (CTZ) as a 
vomiting trigger zone is an area of the medulla 
oblongata that plays an important role in developing 
vomiting reflux [2] [3] [4]. Other risk factors for PONV 
include age over 50, female gender, infection, uremia, 
motion sickness, migraine, hypercalcemia, anxiety, 
etc. [3] [4]. Surgeries such as laparoscopic abdominal 
surgery with peritoneal inflammation, women's 
surgery, strabismus, and ear surgery can cause 
nausea and vomiting [3] [4] [5]. For the prevention of 
postoperative nausea and vomiting in patients with 
high-risk to moderate-risk (Scores 1 to 2), prophylactic 
single-drug administration is recommended, but 
combining treatment with two or more drugs from 
different classes of anti-nausea drugs is more 
effective than single medicine for high-risk patients [3]. 
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It is worth noting that various drugs such as serotonin 
antagonists, anticholinergics, butyrophenones, 
Phenothiazines, steroids and histamine H2-receptor 
antagonists, etc. are used. One of these drugs is 
endometrin, haloperidol, and doxedetomidine, etc. [3]. 
Endonestrone is a serotonin receptor antagonist that 
is very important in preventing nausea and vomiting 
due to surgery and chemotherapy, and it has an anti-
vomiting effect by inhibiting 5HT3 (5-
Hydroxytryptamine type 3) receptors in the vomiting 
centre and chomicosterone [4]. These drugs include 
ondansetron, haloperidol, and dexmedetomidine, etc. 
[3]. Ondansetron is a serotonin receptor antagonist, 
which is very important in preventing nausea and 
vomiting due to surgery and chemotherapy; it 
exhibited an anti-vomiting effect by inhibiting 5-
Hydroxytryptamine type 3 (5-HT3) receptors in the 
vomiting centre and the compressor starting area [4]. 
Haloperidol is a sedative a butyrophenone with an 
antagonistic effect on dopamine receptor 2, which can 
cause nausea and vomiting, by inhibiting dopamine 
receptor 2 in the vomiting centre. Due to its long half-
life, its one-time-only injection can provide an 
appropriate coating within 24 hours [5]. Haloperidol is 
applied as anti-nausea in relieving nausea and 
vomiting, as well as in psychiatry and surgery for the 
management of delusions in people over 40 years of 
age [6]. 
Dexmedetomidine is strong, and a highly 
selective α-2 agonist that attaches to a 
transmembrane G-protein coupled receptor in the 
brain and spinal cord, and affects the function of the 
central nervous system and the central circulatory 
system to produce its analgesic and sympathetic 
effects [7]. Dexmedetomidine is potentially used in 
anaesthesia and intensive care units due to its 
anxiolytic, analgesic, and sympathetic effects as well 
as its hemodynamic constants [7] [8]. Regarding 
available evidence, PONV is one of the main 
complaints of surgery and anaesthesia and is one of 
the risk factors for vomiting after abdominal surgery, 
such as abdominal hysterectomy.  
Therefore, the current study was aimed to 
compare the prophylactic effects of haloperidol, 
ondansetron and dexmedetomidine in reducing PONV 
in patients undergoing an abdominal hysterectomy. 
 
 
Material and Methods 
 
All procedures performed in studies involving 
human participants were in accordance with the 
ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki 
Declaration and its later amendments or comparable 
ethical standards, and was approved by Arak 
University of Medical Sciences Institutional Review 
Board (Protocol number IR.ARAKMU.REC.2017.111; 
October 8, 2017). 
This randomised clinical trial study was 
performed on a subset of patients undergoing 
abdominal hysterectomy referring to Taleghani 
Hospital of Arak, Iran. In this study, 114 patients with 
abdominal hysterectomy were randomly divided into 
three groups (haloperidol, ondansetron and 
dexmedetomidine) using cubull randomisation. 
Patients with non-emergency abdominal hysterectomy 
referred to Taleghani Hospital of Arak were entered 
into the study after obtaining informed consent. They 
were entered into the operating room after 
anesthesiologist's confirmation. All of the patients 
referred to complete monitoring including oxygen 
saturation (SpO2), heart rate (PR), Blood pressure 
(BP), noninvasive blood pressure (NIBC), and body 
temperature measurements. 
The patients were randomly assigned to 3 
groups of 38 patients including the haloperidol group 
(2 mg IV, 1 cc), ondansetron group (4 mg IV, 1 cc) 
and dexmedetomidine group (1 µg/kg IV, 1 cc). 
The injection of these drugs was performed 
after the abdomen pulled out of the uterus. Then, all 
patients received 3-5 cc/kg of crystalloid fluid as 
Compensatory Volume Expansion (CVE), and 
patients underwent general anaesthesia. All patients 
underwent general anesthesia with fentanyl (2 μg/kg), 
midazolam (0.3-0.5 μg/kg), atracurium (0.5-0.7 μg/kg) 
and propofol (2-2 mg/kg). Then, the patients were 
intubated and sub-ventilated. After the endotracheal 
fixation and hemodynamic stability of the patient, the 
surgeon was allowed to start surgery. 
Patients entered the study after obtaining 
informed consent, but none of them was aware of the 
drug received. After the completion of surgery, the 
patients entered the recovery room, and the 
questionnaires including questions about the scour of 
nausea and vomiting, hemodynamic parameters of 
the patient were completed for the patients. All 
patients with vomiting scores of 2 and > 5 were 
treated with metoclopramide. Finally, the obtained 
data were analyzed by statistical software SPSS 23 
and data were presented in the form of statistical 
tables and charts. 
The sample size was determined as reported 
previously [8]. According to a randomised clinical trial, 
114 patients were selected from patients with 
abdominal hysterectomy. 
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Inclusion criteria 
1. All patients suffering from abdominal 
hysterectomy referred to Taleghani Hospital in Arak 
who have informed consent. 2. Patients with ASA 
Class I and II. 3. No history of psychiatric illnesses. 4. 
No Parkinson's disease, motion sickness or history of 
chemotherapy. 5. All patients with general 
anaesthesia. 6. Patients aged 35-60 years 7. A 150 
min maximum duration of surgery 
 
Exclusion criteria 
1. ASA ≥ III and IV. 2. Patients outside the 
age range of 35-60 years. 3. Parkinson's disease. 4. 
The presence of patients without informed consent. 5. 
Psychiatric and psychiatric patients. 6. History of 
chemotherapy. 
 
 
Results 
 
Based on data presented in Table 1 and 
Figure 1, there was no significant difference between 
the three groups of haloperidol, ondansetron and 
dexmedetomidine regarding mean age, BMI and 
mean duration of surgery (P ≥ 0.05). The average age 
of patients in each group was 46 years, followed by an 
average BMI (BMI: 30) and an average duration of 
surgery in three groups (2 hours). 
Table 1: Comparing the mean age, BMI and duration of surgery 
in patients undergoing an abdominal hysterectomy in the three 
groups of haloperidol, ondansetron and dexmedetomidine  
Average/group Ondansetron Haloperidol Dexmedetomidine P-value 
Mean age 8/6-+/8/54 5/4-+/1/54 6/6- +/9/56 P=0.12 
no significant 
BMI average 6/4-+/9/03 8/8 - +/6/03 8/4 - +/1/01 P=0.31 
no significant 
Average duration of 
surgery 
6/9- +/5/118 1/11- +/6/114 5/13-+/4/115 P=0.28 
no significant 
 
With regard to the Table 2, there was a 
significant difference between the three groups in 
terms of vomiting scores in recovery, 2 and 4 hours 
after surgery; the scores of vomiting was significantly 
lower in the ondansetron when comparing with the 
other two groups (P = 0.04 ; P = 0.02 ; P = 0.001).  
 
Figure 1: Comparison of vomiting and nausea scores in patients 
undergoing an abdominal hysterectomy in three groups 
However, there was no significant difference 
between the two groups of haloperidol and 
dexmedetomidine regarding vomiting scores. 
Furthermore, 12 and 24 hours after surgery, the mean 
vomiting scores were identically equal in all three 
groups (P ≥ 0.05); therefore, no significant difference 
was observed between the three groups. 
Table 2: Comparison of vomiting and nausea scores in patients 
undergoing an abdominal hysterectomy in three groups 
Vomiting Scores / Group Ondansetron Haloperidol Dexmedetomidine P-value 
Vomiting recovery score 18/3- +/11/3 51/3- +/05/3 08/3-+/03/3 P=0.04 
significant 
Vomiting score 2 hours 
later 
36/3- +/11/3 58/3-+/41/3 38/3-+/61/3 P=0.02 
significant 
Vomiting score 4 hours 
later 
38/3- +/30/3 31/3-+/03/3 58/3-+/51/3 P=0.001 
Significant 
Vomiting score 12 hours 
later 
3 3 3 P≥0.05 
no significant 
Vomiting score 24 hours 
later 
3 3 3 P≥0.05 
no significant 
Frequency Percentage of 
nausea 
1/13% 6/53% 0/58% P=0.001 
Significant 
 
There was a significant difference in the 
frequency of nausea among the three groups, and the 
incidence of nausea exhibited a significant decrease 
in the ondansetron group as compared to other two 
groups (P = 0.001).  
Table 3: Comparison of the mean dose of metoclopramide 
consumed within 24 hours (mg) after operation in patients 
undergoing an abdominal hysterectomy in the three groups 
together with Average scoring for recovery 
Average / group Ondansetron Haloperidol Dexmedetomidine P-value 
the mean dose of 
metoclopramide 
(Mg) 
31/3- +/36/1 1/1- +/04/5 0/1- +/45/0 P=0.001 
Significant 
Average  scoring 
for recovery 
84/3-+/4/3 1/1-+/04/0 91/3-+/9/3 P=0.12 
no significant 
 
Our study revealed a significant difference 
between the three groups of ondansetron, haloperidol, 
and dexmedetomidine in terms of the mean dose of 
metoclopramide in mg for 24 hours after surgery; 
nevertheless, dosage of metoclopramide in the 
ondansetron group was less than the other two 
groups (P = 0.001; Table 3; Figure 2). 
 
Figure 2: Comparison of the mean dose of metoclopramide 
consumed 24 hours after the operation (mg) and the frequency of 
nausea in patients undergoing an abdominal hysterectomy in the 
three groups 
 
Based on Table 3 and Figure 3, no significant 
difference was found between the three groups 
regarding the average scoring in recovery, so that the 
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scoring average was determined as three in three 
groups (P = 0.12). 
 
Figure 3: Comparison of average scoring in recovery in patients 
undergoing an abdominal hysterectomy in three groups 
 
The frequency of hypotension and 
bradycardia did not exhibit any significant difference 
between the three groups (P = 0.0001). Furthermore, 
the incidence of shivering was not revealed to be 
significant in between the three groups and the 
incidence of shivering in the three groups was found 
to be approximately the same (13.5%) (Table 4). 
Table 4: Frequency of hypotension, bradycardia and shivering 
in patients undergoing an abdominal hysterectomy in three 
groups 
Average / group Ondansetron Haloperidol Dexmedetomidine P-value 
Frequency of 
hypotension 
3 9/13% 6/ 9% P=0.0001 
Significant 
Frequency of 
bradycardia 
3 1/0% 9/13% P=0.0001 
Significant 
Frequency of 
shivering 
4/13% 1/14% 9/13% P=0.11 
no significant 
 
 
 
Discussion 
 
 
Achieving a suitable drug for controlling 
PONV is one of the important goals of 
anesthesiologists. Nausea is an unpleasant sensation 
that is perceived by the person who is aware of the 
imminent occurrence of vomiting after surgery and is 
one of the most common complications after surgery 
in women that occurs during the first 24 hours after 
surgery and anaesthesia [1]. Despite the advances in 
the new drugs for PONV, nausea and vomiting remain 
a common complaint after general anaesthesia, 
especially in women's surgeries [1] [2] [3]. This 
complication can occur between 20% and 30% of 
patients undergoing general anaesthesia after 24 
hours of surgery. Several factors affect the amount of 
nausea and vomiting after surgery, including the type 
of surgery (gynaecological surgery, strabismus, Ear 
surgery), as well as the drugs used and the type of 
anaesthesia [9] [10] [11] [12] [13]. It is noteworthy that 
one of the important concerns of anesthesiologists 
over the years has been the availability of suitable 
drugs for controlling PONV. These drugs are used as 
prophylaxis or for the treatment of PONV [9]. The 
results of previous studies were in agreement with our 
study. In a study conducted by Haddadi et al., in Iran, 
the effects of ondansetron and metoclopyramide and 
dexmedetomidine in the prevention of PONV in 
children undergoing strabismus surgery have been 
investigated, where ondansetron was more effective 
than the other group in controlling PONV [14]. Of 
course, in our study, ondansetron was compared with 
haloperidol and dexmedetomidine, while ondansetron 
has been compared with metoclopramide and 
dexamethasone in the study above. Another study in 
2009, evaluated the effect of ondansetron and the 
combination of ondansetron and dexamethasone in 
preventing PONV in patients with laparoscopic 
cholecystectomy. The results of this study indicated 
that the combination of ondansetron and 
dexamethasone was more effective in preventing 
nausea and vomiting Action [2]. The results of this 
study were in agreement with our findings, suggesting 
the effect of endonestrone on controlling PONV. 
Pradeep Ret al. assessed the efficacy of 
haloperidol with ondansetron in preventing PONV 
after laparoscopic abdominal surgeries. They depicted 
that ondansetron 4 mg is not having a remarkable 
benefit over Haloperidol 2 mg for preventing PONV 
[3]. The results of the mentioned study were not 
consistent with our findings, because the current study 
depicted the effect of ondansetron in controlling 
postoperative nausea and vomiting. The cause of the 
difference in these two studies may be referred to the 
type of surgery. Another study demonstrated that oral 
ondansetron could be more favourable for women 
undergoing cesarean section with spinal anaesthesia 
[4]. The results of this study were consistent with our 
study, which our study has shown the effect of 
ondansetron on reducing PONV. Dexmedetomidine 
has been shown to reduce the incidence and severity 
of PONV, which is similar to dexamethasone. This is 
superior to dexamethasone in reducing postoperative 
pain and taking analgesic drugs over the first 24 hours 
after laparoscopic cholecystectomy [8]. The results of 
the mentioned study are not the same as our study, 
because we compared the effects of the three drugs 
of haloperidol, ondansetron and dexmedetomidine, 
but mentioned study did not compare the effects of 
dexamethasone and dexmedetomidine. 
Furthermore, haloperidol has been equally 
demonstrated to be effective, like dexamethasone, for 
preventing PONV in patients undergoing 
gynaecological laparoscopic surgery [15]. Concisely, 
our findings also revealed that haloperidol, 
ondansetron and dexmedetomidine were effective in 
controlling postoperative nausea and vomiting that are 
in agreement with the aforementioned study. A study 
indicated that ondansetron has favourable effects on 
decreasing as a cost-effective and easily available 
medication for prevention of PONV, where 
endonestrone was nearly 30% more effective than the 
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combination of dexametasone-metocholopromide on 
PONV [16]. 
Our study also suggested a significant effect 
of ondansetron in controlling PONV. Studies have 
shown that exmedetomidine, haloperidol, and 
endonestrone drugs have been effective in controlling 
PONV [17] [18]. However, it should be noted that the 
effect of ondansetron is more than other drugs in most 
studies. Considering the negative effect of 
endonestrone on hemodynamic therapy, it is advised 
to use this drug [17] [19] [20]. The prophylactic use of 
this drug is recommended in women's surgery, 
especially abdominal hysterectomy.  
In conclusion, our data suggested that these 
drugs are effective in reducing PONV in patients 
undergoing a hysterectomy. However, the effect of 
endonestrone on the reduction of postoperative 
nausea and vomiting is more than the other two 
drugs. 
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